Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33733 Results Found
AHA urges unified guidelines to lead COVID-19 vaccine allocation process
The AHA urged the National Academies of Sciences, Engineering and Medicine to adopt a unified set of guidelines to account for the variables associated with all issues of the eventual allocation of COVID-19 vaccine allocation.
FDA partners with European agency for coronavirus vaccine development
FDA said it is partnering with the European Medicines Agency (EMA) on regulatory strategies to facilitate the development of COVID-19 vaccines.
NIH: Experimental COVID-19 vaccine safe, generates immune response
The first human study evaluating an mRNA COVID-19 vaccine made by Moderna Inc. produced neutralizing antibodies in healthy adults, who generally tolerated the vaccine well, the National Institutes of Health reports.
Pfizer COVID-19 vaccine candidate tapped by HHS for large-scale production
The Department of Health and Humans Services said it has an agreement with Pfizer to produce and deliver 100 million doses of the drug maker’s COVID-19 vaccine candidate.
Moderna’s COVID-19 vaccine candidate enters phase 3 clinical trial
The National Institutes of Health announced that a COVID-19 vaccine candidate co-developed by Moderna, Inc. and the National Institute of Allergy and Infectious Diseases has begun a phase 3 clinical trial.
Johnson & Johnson accelerates human trial of coronavirus vaccine
Johnson & Johnson announced it accelerated the initiation of its first human trials of its coronavirus vaccine candidate, with the trial slated to begin in the second half of July.
Agencies award $1B contract to produce vaccine candidate
The departments of Health and Human Services and Defense will pay Janssen Pharmaceutical Companies of Johnson & Johnson $1 billion to manufacture 100 million doses of its COVID-19 vaccine candidate for use in clinical trials, or to vaccinate Americans if authorized by the Food and Drug Administration.
HHS, DOD collaborate to produce COVID-19 vaccines, therapeutics
The Department of Health and Human Services and Department of Defense announced a $1.6 billion agreement to demonstrate commercial-scale manufacturing of Novavax, Inc.’s investigational COVID-19 vaccine.
HHS reserves more vaccine manufacturing capacity; vaccine candidate enters late-stage trial
The Department of Health and Human Services’ Biomedical Advanced Research and Development Authority issued a $265 million task order reserving vaccine manufacturing capacity through December 2021 at an advanced manufacturing center in Texas.
HHS awards McKesson contract to distribute COVID-19 vaccine
McKesson Corporation will serve as a central distributor of future COVID-19 vaccines and related supplies, the departments of Health and Human Services and Defense announced.